Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Biogen Inc. |
| Exelixis, Inc. |
| Moderna, Inc. |
| Regeneron Pharmaceuticals, Inc. |
| BioCryst Pharmaceuticals, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| BIIB | EXEL | MRNA | REGN | BCRX | ISI | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 10% | 23% | -29% | 16% | 19% | -93% | ||
| Fiscal Year - 1 | 8% | 9% | -29% | 16% | 60% | -76% | ||
| Fiscal Year - 2 | 25% | 8% | 50% | 21% | 123% | -40% | ||
| Fiscal Year - 3 | 14% | 11% | 146% | 54% | 292% | -4% | ||
| Fiscal Year - 4 | 33% | 6% | -40% | 32% | -1925% | -40% | ||
| Fiscal Year - 5 | 45% | 22% | -38% | 21% | -249% | 22% | ||
| Average | 23% | 13% | 10% | 27% | -280% | -39% | ||
| Median | 20% | 10% | -29% | 21% | 40% | -40% | ||
| Benchmarks | Ticker | |||||||
| Biogen Inc. | NasdaqGS:BIIB | |||||||
| Exelixis, Inc. | NasdaqGS:EXEL | |||||||
| Moderna, Inc. | NasdaqGS:MRNA | |||||||
| Regeneron Pharmaceuticals, Inc. | NasdaqGS:REGN | |||||||
| BioCryst Pharmaceuticals, Inc. | NasdaqGS:BCRX | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | BIIB | EXEL | MRNA | REGN | BCRX | ISI | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 9,676 | 2,169 | 3,236 | 14,202 | 451 | 705 | ||
| Fiscal Year | 9,676 | 2,169 | 3,236 | 14,202 | 451 | 705 | ||
| Fiscal Year - 1 | 9,836 | 1,830 | 6,848 | 13,117 | 331 | 788 | ||
| Fiscal Year - 2 | 10,173 | 1,611 | 19,263 | 12,173 | 271 | 587 | ||
| Fiscal Year - 3 | 10,982 | 1,435 | 18,471 | 16,072 | 157 | 810 | ||
| Fiscal Year - 4 | 13,445 | 988 | 803 | 8,497 | 18 | 729 | ||
| Fiscal Year - 5 | 14,378 | 968 | 60 | 6,558 | 49 | 1,123 | ||
| Net Income | ||||||||
| Latest Twelve Months | 1,632 | 521 | (3,561) | 4,413 | (89) | (454) | ||
| Fiscal Year | 1,632 | 521 | (3,561) | 4,413 | (89) | (454) | ||
| Fiscal Year - 1 | 1,161 | 208 | (4,714) | 3,954 | (227) | (366) | ||
| Fiscal Year - 2 | 3,047 | 182 | 8,362 | 4,338 | (247) | (270) | ||
| Fiscal Year - 3 | 1,556 | 231 | 12,202 | 8,075 | (184) | (29) | ||
| Fiscal Year - 4 | 4,001 | 112 | (747) | 3,513 | (183) | (444) | ||
| Fiscal Year - 5 | 5,889 | 321 | (514) | 2,116 | (109) | 281 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 26,845 | 2,942 | 18,426 | 33,080 | 517 | 2,990 | ||
| Latest Fiscal Quarter | 28,049 | 2,948 | 14,142 | 37,759 | 490 | 3,004 | ||
| Fiscal Year | 28,049 | 2,948 | 14,142 | 37,759 | 490 | 3,004 | ||
| Fiscal Year - 1 | 26,845 | 2,942 | 18,426 | 33,080 | 517 | 2,990 | ||
| Fiscal Year - 2 | 24,554 | 3,071 | 25,858 | 29,215 | 550 | 2,534 | ||
| Fiscal Year - 3 | 23,877 | 2,616 | 24,669 | 25,435 | 588 | 2,612 | ||
| Fiscal Year - 4 | 24,619 | 2,137 | 7,337 | 17,163 | 335 | 2,390 | ||
| Fiscal Year - 5 | 27,234 | 1,886 | 1,589 | 14,805 | 175 | 3,233 | ||
| Fiscal Year - 6 | 25,289 | 1,422 | 1,962 | 11,735 | 147 | 2,668 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 14,799 | 2,264 | 13,854 | 25,973 | (456) | 387 | ||
| Latest Fiscal Quarter | 16,716 | 2,244 | 10,901 | 29,354 | (476) | 588 | ||
| Fiscal Year | 16,716 | 2,244 | 10,901 | 29,354 | (476) | 588 | ||
| Fiscal Year - 1 | 14,799 | 2,264 | 13,854 | 25,973 | (456) | 387 | ||
| Fiscal Year - 2 | 13,398 | 2,488 | 19,123 | 22,664 | (295) | 573 | ||
| Fiscal Year - 3 | 10,896 | 2,211 | 14,145 | 18,769 | (107) | 772 | ||
| Fiscal Year - 4 | 10,700 | 1,879 | 2,561 | 11,025 | (19) | 743 | ||
| Fiscal Year - 5 | 13,343 | 1,686 | 1,175 | 11,090 | 38 | 1,471 | ||
| Fiscal Year - 6 | 13,040 | 1,287 | 1,530 | 8,757 | 49 | 1,048 | ||